PH26476A - Method of preventing or reducing eosinophilia - Google Patents

Method of preventing or reducing eosinophilia Download PDF

Info

Publication number
PH26476A
PH26476A PH39451A PH39451A PH26476A PH 26476 A PH26476 A PH 26476A PH 39451 A PH39451 A PH 39451A PH 39451 A PH39451 A PH 39451A PH 26476 A PH26476 A PH 26476A
Authority
PH
Philippines
Prior art keywords
antibody
cells
interleukin
bad original
ing
Prior art date
Application number
PH39451A
Other languages
English (en)
Inventor
Robert L Coffman
Donna M Rennick
Original Assignee
Dnax Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23016493&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH26476(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dnax Research Inst filed Critical Dnax Research Inst
Publication of PH26476A publication Critical patent/PH26476A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Optical Head (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pens And Brushes (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Lubricants (AREA)
PH39451A 1988-11-03 1989-11-02 Method of preventing or reducing eosinophilia PH26476A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26690988A 1988-11-03 1988-11-03

Publications (1)

Publication Number Publication Date
PH26476A true PH26476A (en) 1992-07-27

Family

ID=23016493

Family Applications (1)

Application Number Title Priority Date Filing Date
PH39451A PH26476A (en) 1988-11-03 1989-11-02 Method of preventing or reducing eosinophilia

Country Status (17)

Country Link
EP (2) EP0441891A1 (fr)
JP (1) JPH07563B2 (fr)
KR (1) KR960002183B1 (fr)
AT (1) ATE98872T1 (fr)
AU (1) AU633034B2 (fr)
CA (1) CA2002144C (fr)
DE (1) DE68911653T2 (fr)
DK (1) DK81691D0 (fr)
ES (1) ES2062032T3 (fr)
HK (1) HK186196A (fr)
IE (1) IE63063B1 (fr)
IL (1) IL92180A (fr)
MY (1) MY107386A (fr)
NZ (1) NZ243939A (fr)
PH (1) PH26476A (fr)
WO (1) WO1990004979A2 (fr)
ZA (1) ZA898322B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL176393B1 (pl) * 1992-02-06 1999-05-31 Schering Corp Monoklonalne przeciwciało lub jego fragment, które wiąże się swoiście z ludzką interleukiną-5, hybrydoma wydzielająca monoklonalne przeciwciało, które wiąże się swoiście z ludzką interleukiną-5, polipeptyd izolowany DNA, zrekombinowany wektor komórki gospodarza, humanizowane monoklonalne przeciwciało oraz sposób wytwarzania polipeptydu, sposób wytwarzania humanizowanego monoklonalnego przeciwciała i kompozycja farmaceutyczna
AU6000894A (en) * 1993-02-01 1994-08-29 Michel Goldman Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10
GB9412230D0 (en) * 1994-06-17 1994-08-10 Celltech Ltd Interleukin-5 specific recombiant antibodies
ES2277336T3 (es) * 1994-12-23 2007-07-01 Smithkline Beecham Corporation Antagonistas de il-5 recombinantes utiles en el tratamiento de enfermadades mediadas por il-5.
US5783184A (en) * 1994-12-23 1998-07-21 Smithkline Beecham Corporation Method for treatment and diagnosis of IL-5 mediated disorders
US7399837B2 (en) 1995-12-22 2008-07-15 Smithkline Beecham Corporation Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
US5683892A (en) * 1994-12-23 1997-11-04 Smithkline Beecham Corporation DNA encoding recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
CN1326879C (zh) 2002-03-29 2007-07-18 先灵公司 人源抗白细胞介素5单克隆抗体及其制备方法和包含这些抗体的组合物
EP2274009B1 (fr) 2008-03-28 2013-11-13 GlaxoSmithKline LLC Procédés de traitement
EP3634467A4 (fr) 2017-06-06 2021-07-28 GlaxoSmithKline LLC Compositions biopharmaceutiques et procédés pour patients pédiatriques
CN109942706A (zh) * 2017-12-21 2019-06-28 三生国健药业（上海）股份有限公司 结合人il-5的单克隆抗体、其制备方法和用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0666080B1 (fr) * 1987-06-24 2004-01-21 Brigham & Women's Hospital Traitement de maladies auto-immunitaires par administration orale d'auto-antigènes

Also Published As

Publication number Publication date
CA2002144A1 (fr) 1990-05-03
ZA898322B (en) 1990-11-28
WO1990004979A2 (fr) 1990-05-17
WO1990004979A8 (fr) 2005-06-16
DE68911653D1 (de) 1994-02-10
IE893525L (en) 1990-05-03
AU4644889A (en) 1990-05-28
JPH03505211A (ja) 1991-11-14
DK81691A (da) 1991-05-02
IE63063B1 (en) 1995-03-22
DK81691D0 (da) 1991-05-02
DE68911653T2 (de) 1994-04-07
MY107386A (en) 1995-11-30
NZ243939A (en) 1997-07-27
AU633034B2 (en) 1993-01-21
CA2002144C (fr) 2000-03-28
JPH07563B2 (ja) 1995-01-11
ATE98872T1 (de) 1994-01-15
HK186196A (en) 1996-10-11
EP0367596A1 (fr) 1990-05-09
KR900701320A (ko) 1990-12-01
IL92180A0 (en) 1990-07-26
IL92180A (en) 1997-04-15
EP0367596B1 (fr) 1993-12-22
ES2062032T3 (es) 1994-12-16
EP0441891A1 (fr) 1991-08-21
KR960002183B1 (ko) 1996-02-13

Similar Documents

Publication Publication Date Title
Hammerberg et al. Characterization of monoclonal antibodies directed against swine leukocytes
PH26476A (en) Method of preventing or reducing eosinophilia
JP4736037B2 (ja) ヒトｇｍ−ｃｓｆに結合するヒトのモノクローナル抗体並びにその抗原結合部分
JP2021054826A (ja) Ｃｄ４０ｌ関連疾患または障害を治療するための抗ｃｄ４０ｌ抗体及び方法
WO1999003495A1 (fr) Anticorps monoclonal murin agoniste utilise en tant que stimulant pour la megacaryocytopoiese
US12364742B2 (en) Antigen-specific T cells for inducing immune tolerance
GB2398783A (en) A method for producing immortalised human B memory lymphocytes
Gayet et al. Impact of IgA isoforms on their ability to activate dendritic cells and to prime T cells
EP1835937A2 (fr) Compositions et procédés de traitement d'infections virales
JPH05505823A (ja) 細胞成長抑制法およびそれに有用な組成物
JP2002540771A (ja) 抗体構築物およびケモカイン構築物ならびに自己免疫疾患の治療におけるそれらの使用
JP4588210B2 (ja) 免疫応答を増強するため、およびインビトロでのモノクローナル抗体の産生のための方法および組成物
NZ216249A (en) Invitro selective cultivation of immunoglobulin producing cells, hybridomas and monoclonal antibodies
JPH05504058A (ja) 敗血症性ショック治療用医薬組成物
Fernandes et al. Polymeric IgA-secreting and mucosal homing pre-plasma cells in normal human peripheral blood
US12163965B2 (en) Methods of culturing and characterizing antibody secreting cells
EP0447489A1 (fr) Anticorps humains specifiques de plaquettes
JPH05509318A (ja) インターロイキン―４とインターロイキン―１βが共働してＶＣＡＭ―１を誘導する
CN116284448A (zh) 一种超抗原参与的三功能t细胞衔接器及其应用
Tamma et al. IgD receptors on murine T-helper cells bind to Fd and Fc regions of immunoglobulin D.
JPH03503844A (ja) Ｌａｋ細胞サイトトキシン
JPH03500363A (ja) ヒトｔ細胞表面レセプターのガンマ鎖のエピトープを認識する単クローン性抗体
Shih et al. Monoclonal antibody J11d. 2 recognizes cell cycle-dormant, primitive hematopoietic progenitors of mice
SHARED et al. Stimulation of distinct T cell subsets in MLR using human macrophage hybridomas differentially expressing class II antigens
Vanhove et al. Differentiation of membrane IgE+ rat B cells into IgE-secreting cells